Chang-Wan Son
Director/Board Member at ILSUNG IS CO., LTD.
Profile
Chang-Wan Son is an Independent Director at Ilsung Pharmaceutical Co., Ltd.
He previously served as an Independent Director at Goldenbridge No.
4 Special Purpose Acquisition Co., Ltd.
and as an Associate Professor at YONSEI LAW SCHOOL.
He is a graduate of YONSEI LAW SCHOOL.
Chang-Wan Son active positions
| Companies | Position | Start |
|---|---|---|
| ILSUNG IS CO., LTD. | Director/Board Member | 2020-03-19 |
Former positions of Chang-Wan Son
| Companies | Position | End |
|---|---|---|
Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd.
 Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd. engages in the mergers and acquisitions. It is formed only to have a purpose of merging and acquiring of growth-oriented industries. The company was founded on September 4, 2015 and is headquartered in Seoul, South Korea. | Director/Board Member | 2017-03-23 |
| YONSEI LAW SCHOOL | Corporate Officer/Principal | - |
Training of Chang-Wan Son
| YONSEI LAW SCHOOL | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ILSUNG IS CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd.
Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd. engages in the mergers and acquisitions. It is formed only to have a purpose of merging and acquiring of growth-oriented industries. The company was founded on September 4, 2015 and is headquartered in Seoul, South Korea. | Miscellaneous |
- Stock Market
- Insiders
- Chang-Wan Son
